Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib

MLA

Kwai Fung Hui, et al. “Counteracting Survival Functions of EBNA3C in Epstein-Barr Virus (EBV)-Driven Lymphoproliferative Diseases by Combination of SAHA and Bortezomib.” Oncotarget, vol. 9, no. 38, May 2018, pp. 25101–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d213e5b3e2bfbd96e9ba6b2792ebd5a5&authtype=sso&custid=ns315887.

APA

Kwai Fung Hui, Po Ling Yeung, Alan K. S. Chiang, & Kam Pui Tam. (2018). Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib. Oncotarget, 9(38), 25101–25114.

Chicago

Kwai Fung Hui, Po Ling Yeung, Alan K. S. Chiang, and Kam Pui Tam. 2018. “Counteracting Survival Functions of EBNA3C in Epstein-Barr Virus (EBV)-Driven Lymphoproliferative Diseases by Combination of SAHA and Bortezomib.” Oncotarget 9 (38): 25101–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d213e5b3e2bfbd96e9ba6b2792ebd5a5&authtype=sso&custid=ns315887.